Cargando…
Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death
Autores principales: | Gupta, Sanjay, Milbrandt, Eric B, Chelluri, Lakshmipathi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794444/ https://www.ncbi.nlm.nih.gov/pubmed/17094794 http://dx.doi.org/10.1186/cc5071 |
Ejemplares similares
-
Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008) -
Dirty mouth? Should you clean it out? Decontamination for the prevention of pneumonia and mortality in the ICU
por: Shibli, Adeel B, et al.
Publicado: (2010) -
NGAL: an emerging tool for predicting severity of AKI is easily detected by a clinical assay
por: Gabbard, Wes, et al.
Publicado: (2010) -
A disheartening story: Aprotinin in cardiac surgery
por: Lien, Marcus, et al.
Publicado: (2006) -
Nesiritide – Run and hide?
por: Kapoor, Ajoy, et al.
Publicado: (2006)